Collectively, our study demonstrated that CDX2 inhibits EMT and metastasis of CRC by regulation of Snail expression and β-catenin stabilisation through PI3K/Akt/GSK-3β signalling. The gene discussed is GSK3B; the disease is colorectal carcinoma.